An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer.

MLA

Kong, Lingping, et al. “An Engineered DNA Aptamer-Based PROTAC for Precise Therapy of P53-R175H Hotspot Mutant-Driven Cancer.” Science Bulletin, vol. 69, no. 13, July 2024, pp. 2122–35. EBSCOhost, https://doi.org/10.1016/j.scib.2024.05.017.

APA

Kong, L., Meng, F., Zhou, P., Ge, R., Geng, X., Yang, Z., Li, G., Zhang, L., Wang, J., Ma, J., Dong, C., Zhou, J., Wu, S., Zhong, D., & Xie, S. (2024). An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer. Science Bulletin, 69(13), 2122–2135. https://doi.org/10.1016/j.scib.2024.05.017

Chicago

Kong, Lingping, Fanlu Meng, Ping Zhou, Ruixin Ge, Xiaoshan Geng, Zhihao Yang, Guo Li, et al. 2024. “An Engineered DNA Aptamer-Based PROTAC for Precise Therapy of P53-R175H Hotspot Mutant-Driven Cancer.” Science Bulletin 69 (13): 2122–35. doi:10.1016/j.scib.2024.05.017.